PDB20 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO INSULIN DETEMIR FROM ORAL ANTIDIABETICS OR NPH IN THE CZECH SETTING; DATA FROM THE PREDICTIVE STUDY
May 1, 2009, 00:00
10.1016/S1098-3015(10)73564-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)73564-6/fulltext
Title :
PDB20 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO INSULIN DETEMIR FROM ORAL ANTIDIABETICS OR NPH IN THE CZECH SETTING; DATA FROM THE PREDICTIVE STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73564-6&doi=10.1016/S1098-3015(10)73564-6
First page :
Section Title :
Open access? :
No
Section Order :
12